ResearcherBoston UniversityActive in the last 2 years

Bo Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6043-8774; OpenAlex author ID A5089972574. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 4

Single-cell transcriptome analysis identifies a novel tumor-associated macrophage subtype predicting better prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fcell.2024.1466767 ↗
Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer. Co-author DOI 10.1016/j.jtemb.2021.126734 ↗
Plasma IFN-γ-inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2019.01.015 ↗
The role of FADD in pancreatic cancer cell proliferation and drug resistance. Co-author DOI 10.3892/ol.2017.5636 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zichun Hua · 3 shared papers, 2017–2024 · strength 0.55
Xiaonan Wang · 1 shared paper, 2024 · strength 0.31
- Paper Single-cell transcriptome analysis identifies a novel tumor-associated macrophage subtype predicting better prognosis i… DOI 10.3389/fcell.2024.1466767 ↗
Xiao Chen · 1 shared paper, 2021 · strength 0.16
- Paper Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer. DOI 10.1016/j.jtemb.2021.126734 ↗
Shulin Yu · 1 shared paper, 2019 · strength 0.11
- Paper Plasma IFN-γ-inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pa… DOI 10.1016/j.pan.2019.01.015 ↗
Zhen Chen · 1 shared paper, 2019 · strength 0.11
- Paper Plasma IFN-γ-inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pa… DOI 10.1016/j.pan.2019.01.015 ↗
Peng Wang · 1 shared paper, 2019 · strength 0.11
- Paper Plasma IFN-γ-inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pa… DOI 10.1016/j.pan.2019.01.015 ↗
Ling Mei Qian · 1 shared paper, 2019 · strength 0.11
- Paper Plasma IFN-γ-inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pa… DOI 10.1016/j.pan.2019.01.015 ↗
Zhiqiang Meng · 1 shared paper, 2019 · strength 0.11
- Paper Plasma IFN-γ-inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pa… DOI 10.1016/j.pan.2019.01.015 ↗
Rong Zhang · 1 shared paper, 2017 · strength 0.08
- Paper The role of FADD in pancreatic cancer cell proliferation and drug resistance. DOI 10.3892/ol.2017.5636 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.